poisar

Stocks · News reference

Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer

Fiscal.ai

Natera, Inc. has entered into a clinical collaboration agreement with Incyte to evaluate the investigational bispecific immunotherapy INCA33890 in a new Phase II study for colorectal cancer patients.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading